By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Agios Pharmaceuticals 

38 Sidney Street
2nd Floor
Cambridge  Massachusetts  02139-4169  U.S.A.
Phone: 617-649-8600 Fax: n/a


SEARCH JOBS








Company News
Agios (AGIO) To Webcast Conference Call Of Second Quarter 2015 Financial Results On August 6, 2015 7/30/2015 7:44:17 AM
Agios (AGIO) Appoints Maykin Ho, Ph.D., To Its Board Of Directors 6/24/2015 11:50:37 AM
Agios (AGIO) Announces First Patient Dosed With AG-881 In Phase 1 Study In Patients With Advanced Solid Tumors With An IDH Mutation 6/24/2015 7:42:26 AM
Celgene (CELG) And Agios (AGIO) Deliver Some Great "Bad" News 6/18/2015 7:23:27 AM
Agios (AGIO) Announces New Data From Ongoing Phase 1 Dose Escalation And Expansion Trial Of AG-221 Showing Durable Clinical Activity In Patients With Advanced Hematologic Malignancies 6/12/2015 10:48:20 AM
Agios (AGIO) Announces New Data from Ongoing Phase 1 Trial Of AG-120 Showing Durable Clinical Activity In Patients With Advanced Hematologic Malignancies 6/12/2015 10:46:10 AM
Agios (AGIO) Announces FDA Orphan Drug Designation Granted To AG-120 For Treatment Of IDH1-Mutant Positive Acute Myelogenous Leukemia 6/11/2015 10:58:35 AM
Agios (AGIO) To Present Clinical And Preclinical Data At The 20th Congress Of The European Hematology Association 5/21/2015 12:24:45 PM
Agios (AGIO) Announces FDA Fast Track Designation Granted To AG-120 For Treatment Of Patients With Acute Myelogenous Leukemia With An IDH1 Mutation 5/18/2015 7:36:13 AM
Agios (AGIO) To Webcast Conference Call Of First Quarter 2015 Financial Results On May 7, 2015 4/29/2015 7:44:45 AM
12345678910...
//-->